Crossref
journal-article
Elsevier BV
Mutation Research/Reviews in Mutation Research (78)
References
149
Referenced
70
10.1038/358015a0
/ Nature / Cancer: p53, guardian of the genome by Lane (1992)- X.W. Wang, C.C. Harris, Tp53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy, Cancer Surveys, Genetic Instability in Cancer, Vol. 28, 1996, pp. 169–196.
10.1007/s000180050271
/ Cell. Mol. Life Sci. / Covalent and noncovalent modifiers of the p53 protein by Jayaraman (1999)10.1006/jmbi.1996.0560
/ J. Mol. Biol. / How phosphorylation regulates the activity of p53 by Steegenga (1996)10.1016/S0024-3205(96)00479-1
/ Life Sci. / p53 phosphorylation: biochemical and functional consequences by Milczarek (1997){'key': '10.1016/S1383-5742(01)00075-8_BIB6', 'first-page': '229', 'article-title': 'The p53 pathway and cancer therapy', 'volume': '11', 'author': 'El-Diery', 'year': '1998', 'journal-title': 'Cancer J.'}
/ Cancer J. / The p53 pathway and cancer therapy by El-Diery (1998)10.1080/095530098141005
/ Int. J. Radiat. Biol. / New developments in the multi-site phosphorylation and integration of stress signaling at p53 by Meek (1998)10.1038/sj.onc.1202952
/ Oncogene / Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53 by Albrectson (1999)10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3
/ J. Pathol. / The p53 pathway by Prives (1999)10.1038/sj.onc.1203015
/ Oncogene / Regulation of p53 in response to DNA damage by Lakin (1999)10.1038/sj.onc.1203013
/ Oncogene / p53 regulation by translational modification and nuclear retention in response to diverse stresses by Jimenez (1999)10.1046/j.1432-1327.2001.02225.x
/ Eur. J. Biochim. / Post-translational modifications and activation of p53 by genotoxic stresses by Apella (2001)10.1038/542
/ Nat. Genet. / ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 protein by Waterman (1998)10.1016/S0092-8674(00)80521-8
/ Cell / Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain by Gu (1997)10.1093/emboj/18.22.6455
/ EMBO J. / SUMO-1 modification activates the transcriptional response of p53 by Rodriguez (1999)10.1093/emboj/18.22.6462
/ EMBO J. / Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1 by Gostissa (1999)10.1093/nar/26.1.205
/ Nucl. Acids Res. / IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualization tools by Hainut (1998)10.1038/sj.onc.1202298
/ Oncogene / Evolutionary conservation and somatic mutation hotspots maps of p53: correlation with p53 protein structural and functional features by Walker (1999){'key': '10.1016/S1383-5742(01)00075-8_BIB19', 'first-page': '4855', 'article-title': 'Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis', 'volume': '54', 'author': 'Greenblatt', 'year': '1994', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis by Greenblatt (1994)10.1016/S0027-5107(00)00022-1
/ Mutat. Res. / p53 mutational spectra and the role of methylated CpG sequences (review) by Pfeifer (2000)10.1038/350427a0
/ Nature / Mutational hotspot in the p53 gene in human hepatocellular carcinomas by Hsu (1991){'key': '10.1016/S1383-5742(01)00075-8_BIB22', 'first-page': '33346', 'article-title': 'Crystal structure of a p53 tumor suppressor–DNA complex: understanding tumorigenic mutations', 'volume': '265', 'author': 'Cho', 'year': '1994', 'journal-title': 'Nature'}
/ Nature / Crystal structure of a p53 tumor suppressor–DNA complex: understanding tumorigenic mutations by Cho (1994)10.1002/(SICI)1097-4652(199711)173:2<247::AID-JCP30>3.0.CO;2-A
/ J. Cell. Phys. / p53 tumor-suppressor gene: clues to molecular carcinogenesis by Wang (1997)10.1038/sj.onc.1202964
/ Oncogene / Dissociation of the recombination control and the sequence-specific transactivation function of p53 by Dudenhoffer (1999)10.1007/s000180050266
/ Cell. Mol. Life Sci. / The dual role model for p53 in maintaining genomic integrity by Janus (1999){'key': '10.1016/S1383-5742(01)00075-8_BIB26', 'first-page': '6304', 'article-title': 'Participation of p53 protein in the cellular response to DNA damage', 'volume': '51', 'author': 'Kastan', 'year': '1991', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Participation of p53 protein in the cellular response to DNA damage by Kastan (1991)10.1016/0092-8674(93)90500-P
/ Cell / WAF1, a potential mediator of p53 tumor suppression by El-Diery (1993)10.1002/(SICI)1098-2280(1996)27:1<10::AID-EM2>3.0.CO;2-I
/ Environ. Mol. Mutagen. / Cell-cycle traverse in AHH-1 TK+/− human lymphoblastoid cells exposed to the chromosomal mutagen, m-amsa by Morris (1996)10.1073/pnas.96.5.2147
/ Proc. Natl. Acad. Sci. / p53 regulates a G2 checkpoint through cyclin B1 by Innocente (1999)10.1007/BF00048057
/ Cancer Metast. Rev. / Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview by Wyllie (1992)10.1038/sj.onc.1202356
/ Oncogene / Inhibition of RNA polymerase II as a trigger for the p53 response by Ljungman (1999){'key': '10.1016/S1383-5742(01)00075-8_BIB32', 'first-page': '5407', 'article-title': 'bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced glucocorticoids and multiple chemotherapeutic drugs', 'volume': '52', 'author': 'Miyashita', 'year': '1992', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced glucocorticoids and multiple chemotherapeutic drugs by Miyashita (1992){'key': '10.1016/S1383-5742(01)00075-8_BIB33', 'first-page': '1791', 'article-title': 'Immediate up-regulation of bax expression by p53 but not by TGFβ1: a paradigm for distinct apoptotic pathways', 'volume': '9', 'author': 'Selvakumaran', 'year': '1994', 'journal-title': 'Oncogene'}
/ Oncogene / Immediate up-regulation of bax expression by p53 but not by TGFβ1: a paradigm for distinct apoptotic pathways by Selvakumaran (1994){'key': '10.1016/S1383-5742(01)00075-8_BIB34', 'first-page': '3743', 'article-title': 'Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis', 'volume': '9', 'author': 'Zhan', 'year': '1994', 'journal-title': 'Oncogene'}
/ Oncogene / Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis by Zhan (1994)10.1038/sj.onc.1204067
/ Oncogene / Negative regulation of bcl-2 expression by p53 in hematopoietic cells by Wu (2001)10.1042/bj3410233
/ Biochem. J. / The mitochondrial permeability transition pore and its role in cell death by Crompton (1999)10.1074/jbc.275.21.16202
/ J. Biol. Chem. / Death signal-induced localization of p53 protein to mitochondria: a potential role in apoptotic signaling by Marchenko (2000)10.1096/fj.00-0262com
/ FASEB J. / Direct influence of the p53 tumor suppressor on mitochondrial biogenesis and function by Donahue (2001)10.1074/jbc.274.10.6469
/ J. Biol. Chem. / Inhibition of p53 transcriptional activity by bcl-2 requires its membrane-anchoring domain by Froesch (1999)10.1038/sj.onc.1202310
/ Oncogene / Inhibitory effect of bcl-2 on p53-mediated transactivation following genotoxic stress by Zhan (1999)10.1038/sj.onc.1202576
/ Oncogene / Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress by Amundson (1998)10.1006/scbi.1998.0097
/ Semin. Cancer Biol. / Regulation of p53 downstream genes by El-Diery (1998)10.1016/S0014-5793(99)00505-0
/ FEBS Lett. / Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery by Offer (1999)10.1038/sj.onc.1202000
/ Oncogene / p53 is involved in regulation of the DNA repair gene O6-methylguanine–DNA methyltransferase (MGMT) by DNA damaging agents by Grombacher (1998)10.1073/pnas.96.2.424
/ Proc. Natl. Acad. Sci. / Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair by Hwang (1999)10.1073/pnas.92.19.8876
/ Proc. Natl. Acad. Sci. / Li–Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance by Ford (1995)10.1074/jbc.272.44.28073
/ J. Biol. Chem. / Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts by Ford (1997){'key': '10.1016/S1383-5742(01)00075-8_BIB48', 'first-page': '1053', 'article-title': 'Involvement of the p53 tumor suppressor in repair of UV-type DNA damage', 'volume': '10', 'author': 'Smith', 'year': '1995', 'journal-title': 'Oncogene'}
/ Oncogene / Involvement of the p53 tumor suppressor in repair of UV-type DNA damage by Smith (1995){'key': '10.1016/S1383-5742(01)00075-8_BIB49', 'first-page': '599', 'article-title': 'Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation', 'volume': '58', 'author': 'Ford', 'year': '1998', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation by Ford (1998)10.1073/pnas.96.26.15038
/ Proc. Natl. Acad. Sci. / Human cells compromised for p53 function exhibit defective global and transcription-coupled nucleotide excision repair, whereas cells compromised for pRb function are defective only in global repair by Therrien (1999)10.1038/ng0695-188
/ Nat. Genet. / p53 modulation of TFIIH-associated nucleotide excision repair activity by Wang (1995)10.1073/pnas.91.1.413
/ Proc. Natl. Acad. Sci. / p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer by Bakalkin (1994)10.1073/pnas.92.21.9455
/ Proc. Natl. Acad. Sci. / The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation by Reed (1995)10.1016/S0092-8674(05)80007-8
/ Cell / Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus by Jayaraman (1995)10.1093/carcin/22.6.851
/ Carcinogenesis / p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding by Liu (2001)10.1038/sj.onc.1202941
/ Oncogene / Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint by Saintigny (1999)10.1038/sj.onc.1200931
/ Oncogene / Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein by Bertrand (1997)10.1038/sj.onc.1201143
/ Oncogene / Inactivation of p53 results in high rates of homologous recombination by Meekel (1997)10.1093/nar/25.19.3868
/ Nucl. Acids Res. / Interaction of p53 with the human RAD51 protein by Buchop (1997)10.1128/MCB.18.9.5332
/ Mol. Cell. Biol. / Specific mismatch recognition in heteroduplex intermediates suggests a role in fidelity control of homologous recombination by Dudenhoffer (1998)10.1016/S0092-8674(00)81309-4
/ Cell / p53 protein exhibits 3′–5′ exonuclease activity by Mummenbrauer (1996)10.1128/MCB.19.3.2155
/ Mol. Cell. Biol. / Different regulation of the p53 core domain activities 3′–5′ exonuclease and sequence-specific DNA binding by Janus (1999)10.1093/emboj/20.10.2596
/ EMBO J. / A novel role for the bcl-2 protein family: specific suppression of the RAD51 recombination pathway by Saintigny (2001)10.1016/S0300-9084(99)80042-X
/ Biochimie / The contribution of homologous recombination in preserving genome integrity in mammalian cells by Thompson (1999)10.1073/pnas.96.18.10355
/ Proc. Natl. Acad. Sci. / The interaction between p53 and DNA topoisomerase-I is regulated differently in cells with wild-type and mutant p53 by Gobert (1999){'key': '10.1016/S1383-5742(01)00075-8_BIB66', 'first-page': '2091', 'article-title': 'Wild-type and mutant forms of p53 activate human topoisomersase I: a possible mechanism for gain of function in mutants', 'volume': '58', 'author': 'Albor', 'year': '1998', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Wild-type and mutant forms of p53 activate human topoisomersase I: a possible mechanism for gain of function in mutants by Albor (1998)10.1093/carcin/20.8.1439
/ Carcinogenesis / Poly ADP-ribose-mediated regulation of p53 complexed with topoisomerase I following ionizing radiation by Smith (1999){'key': '10.1016/S1383-5742(01)00075-8_BIB68', 'first-page': '4538', 'article-title': 'p53 dependence of topoisomerase I recruitment in vivo', 'volume': '60', 'author': 'Mao', 'year': '2000', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / p53 dependence of topoisomerase I recruitment in vivo by Mao (2000)10.1128/MCB.17.1.389
/ Mole. Cell. Biol. / Inhibition of DNA topoisomerase IIα gene expression by the p53 tumor suppressor by Wang (1997)10.1006/bbrc.1997.6539
/ Biochem. Biophys. Res. Commun. / Binding of wild-type p53 by topoisomerase II and overexpression of topoisomerase in human hepatocellular carcinoma by Yuwen (1997)10.1074/jbc.M002081200
/ J. Biol. Chem. / The p53 tumor suppressor stimulates the catalytic activity of human topoisomerase IIα by enhancing the rate of ATP hydrolysis by Kwon (2000)10.1006/excr.1999.4772
/ Exp. Cell Res. / Human topoisomerase IIα, and IIβ interact with the C-terminal region of p53 by Cowell (2000)10.1073/pnas.90.8.3319
/ Proc. Natl. Acad. Sci. / The p53 protein is an unusually shaped tetramer that binds directly to DNA by Friedman (1993)10.1016/0092-8674(91)90384-B
/ Cell / Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation by Milner (1991)10.1128/MCB.11.1.12
/ Mol. Cell. Biol. / Tumor suppressor p53: analysis of wild-type and mutant p53 complexes by Milner (1991){'key': '10.1016/S1383-5742(01)00075-8_BIB76', 'first-page': '141', 'article-title': 'Mutant p53 is not fully dominant over endogenous wild type p53 in a colorectal adenoma cell line as demonstrated by induction of mdm2 protein and retention of a p53 dependent G1 arrest after irradiation', 'volume': '11', 'author': 'Williams', 'year': '1995', 'journal-title': 'Oncogene'}
/ Oncogene / Mutant p53 is not fully dominant over endogenous wild type p53 in a colorectal adenoma cell line as demonstrated by induction of mdm2 protein and retention of a p53 dependent G1 arrest after irradiation by Williams (1995)10.1096/fasebj.7.10.8344485
/ FASEB J. / A comparison of the biological activities of wild-type and mutant p53 by Zambetti (1993)10.1038/sj.cdd.4400624
/ Cell Death Differ. / Structure, function and regulation of p63 and p73 by Levero (1999)10.1038/38298
/ Nature / p73 is a human p53-related protein that can induce apoptosis by Jost (1997)10.1016/S0092-8674(00)80540-1
/ Cell / Monoalleleically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers by Kaghad (1997){'key': '10.1016/S1383-5742(01)00075-8_BIB81', 'first-page': '5061', 'article-title': 'The potential tumor suppressor p73 differentially regulates cellular p53 target genes', 'volume': '58', 'author': 'Zhu', 'year': '1998', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / The potential tumor suppressor p73 differentially regulates cellular p53 target genes by Zhu (1998)10.1038/21697
/ Nature / Interaction of c-abl and p73α and their collaboration to induce apoptosis by Agami (1999)10.1038/21690
/ Nature / The tyrosine kinase c-abl regulates p73 in apoptotic response to cisplatin-induced DNA damage by Gong (1999)10.1038/21704
/ Nature / p73 is regulated by tyrosine kinase c-abl in the apoptotic response to DNA damage by Yuan (1999)10.1074/jbc.274.26.18709
/ J. Biol. Chem. / p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53 by Davison (1999)10.1128/MCB.19.2.1438
/ Mol. Cell. Biol. / p73 function is inhibited by tumor-derived p53 mutants in mammalian cells by DiComo (1999)10.1038/75586
/ Nat. Genet. / A common polymorphism acts as an intragenic modifier of mutant p53 behavior by Marin (2000)10.1016/S1097-2765(00)80275-0
/ Mol. Cell / p63, a p53 homologue at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities by Yang (1998)10.1016/S0959-437X(99)00038-6
/ Curr. Opin. Genet. Dev. / The ARF/p53 pathway by Sherr (2000)10.1038/sj.neo.7900073
/ Neoplasia / Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress by Ljungman (2000)10.1038/sj.onc.1203012
/ Oncogene / Regulation of p53 stability by Ashcroft (1999)10.1016/S0959-437X(99)80004-5
/ Curr. Opin. Genet. Dev. / The INK4A/ARF locus and its two gene products by Sharpless (1999)10.1073/pnas.96.12.6937
/ Proc. Natl. Acad. Sci. / p19ARF stabilizes p53 by blocking nucleo-cytoplasmic shuttling of mdm2 by Tao (1999)10.1128/MCB.20.7.2517-2528.2000
/ Mol. Cell. Biol. / Cooperative signals governing the ARF–mdm2 interaction and nuclear localization of the complex by Weber (2000)10.1101/gad.12.19.2984
/ Genes Dev. / Tumor surveillance via the ARF-p53 pathway by Sherr (1998)10.1038/278261a0
/ Nature / T-antigen is bound to host protein in SV40-transformed cells by Lane (1979)10.1006/scbi.1999.0142
/ Semin. Cancer Biol. / The interaction between p53 and papillomaviruses by Mantovani (1999)-
H. Zimmerman, R. Degenkolbe, H.U. Bernard, M.J. O’Conner, The human papillomavirus Type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300, 1999.
(
10.1128/JVI.73.8.6209-6219.1999
) 10.1038/sj.onc.1202953
/ Oncogene / The role of E6–p53 interaction in the molecular pathogenesis of HPV by Thomas (1999)10.1128/JVI.72.4.3146-3154.1998
/ J. Virol. / Adenovirus E1B 55K represses p53 activation in vitro by Martin (1998)10.1128/JVI.71.9.6629-6640.1997
/ J. Virol. / Adenovirus type 12 early region 1B 54K protein significantly extends the life span of normal mammalian cells in culture by Gallimore (1997)10.1016/0027-5107(93)90188-L
/ Mutat. Res. / Different cytotoxic and mutagenic responses induced by X-rays in two human lymphoblastoid cell lines derived from a single donor by Amundson (1993)10.1016/0027-5107(93)90074-P
/ Mutat. Res. / DNA-sequence specificity of mutations at the thymidine kinase locus by Grosovsky (1993)10.1128/MCB.14.9.5850
/ Mol. Cell. Biol. / Different capacities for recombination in closely related human lymphoblastoid cell lines with different mutational responses to X-irradiation by Xia (1994)10.1016/0165-7992(95)90055-1
/ Mutat. Res. / The relative radiosensitivity of TK6 and WIL2-NS lymphoblastoid cells derived from a common source is primarily determined by their p53 mutational status by Zhen (1995){'key': '10.1016/S1383-5742(01)00075-8_BIB106', 'first-page': '12', 'article-title': 'Altered p53 status correlated with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines', 'volume': '55', 'author': 'Xia', 'year': '1995', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Altered p53 status correlated with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines by Xia (1995)10.1016/S0027-5107(96)00223-0
/ Mutat. Res. / Cytotoxic and mutagenic responses to X-rays and chemical mutagens in normal and p53-mutated human lymphoblastoid cells by Honma (1995)10.1128/MCB.17.8.4774
/ Mol. Cell. Biol. / Illegitimate recombination leading to allelic loss and unbalanced translocation in p53-mutated human lymphoblastoid cells by Honma (1997)10.1016/S0027-5107(96)00193-5
/ Mutat. Res. / The tumor suppressor p53 modifies mutational processes in a human lymphoblasotid cell line by Xia (1997)10.1002/1098-2744(200008)28:4<203::AID-MC3>3.0.CO;2-1
/ Mol. Carcinog. / Requirement of wild-type p53 protein for maintenance of chromosomal integrity by Honma (2000)10.1038/sj.onc.1201026
/ Oncogene / Abrogation of p53 function by HPV16E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphpblastoid cells by Yu (1997){'key': '10.1016/S1383-5742(01)00075-8_BIB112', 'first-page': '3073', 'article-title': 'Radiation-induced mutations at the autosomal thymidine kinase locus are not elevated in p53-null cells', 'volume': '59', 'author': 'Chuang', 'year': '1999', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Radiation-induced mutations at the autosomal thymidine kinase locus are not elevated in p53-null cells by Chuang (1999)10.1016/0027-5107(84)90110-6
/ Mutat. Res. / Assay for gene mutation in a human lymphoblast line, AHH-1, competent for xenobiotic metabolism by Crespi (1984)10.1093/mutage/10.1.53
/ Mutagenesis / Extensive loss of heterozygosity accounts for differential mutation rate on chromosome 17q in human lymphoblasts by Dobo (1995)10.1016/0027-5107(96)00133-9
/ Mutat. Res. / A mutation in the p53 tumor suppressor gene of AHH-1 TK+/− human lymphoblastoid cells by Morris (1996)10.1016/S0027-5107(98)00126-2
/ Mutat. Res. / p53, mutations and apoptosis in genistein-exposed lymphoblastoid cells by Morris (1998)10.1016/S0027-5107(00)00170-6
/ Mutat. Res. / Evaluation of the genotoxicity of the phytoestrogen, coumestral, in AHH-1 TK+/− human lymphoblasotid cells by Domon (2001)10.1093/carcin/18.9.1701
/ Carcinogenesis / The influence of cellular apoptotic capacity on N-nitrosodimethylamine-induced loss of heterozygosity mutations in human cells by Dobo (1997)10.1073/pnas.84.21.7716
/ Proc. Natl. Acad. Sci. / Rearrangement of the p53 gene in human osteogenic sarcomas by Masuda (1987)10.1093/carcin/18.4.695
/ Carcinogenesis / Decrease in the frequency of X-ray-induced mutation by wild-type p53 protein in human osteosarcoma cells by Yamagishi (1997)10.1016/S0304-3835(97)00406-0
/ Cancer Lett. / Reduced UV-induced mutations in human osteosarcoma cells stability expressing transfected wild-type p53 cDNA by Yagi (1998){'key': '10.1016/S1383-5742(01)00075-8_BIB122', 'first-page': '4420', 'article-title': 'p53 inactivation by HPV16E6 results in increased mutagenesis in human cells', 'volume': '55', 'author': 'Havre', 'year': '1995', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / p53 inactivation by HPV16E6 results in increased mutagenesis in human cells by Havre (1995)10.1093/carcin/16.10.2295
/ Carcinogenesis / Induction of p53 in mouse cells decreases mutagenesis by UV radiation by Yuan (1995)10.2307/3579414
/ Radiat. Res. / Spectra of X-ray-induced and spontaneous intragenic HPRT mutations in closely related human cells differentially expressing the p53 tumor suppressor gene by Phillips (1997)10.1038/356215a0
/ Nature / Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors by Donehower (1992)10.1016/S0960-9822(00)00002-6
/ Curr. Biol. / Tumor spectrum analysis in p53-mutant mice by Jacks (1994){'key': '10.1016/S1383-5742(01)00075-8_BIB127', 'first-page': '603', 'article-title': 'Tumor-incidence, spectrum and ploidy in mice with a large deletion in the p53 gene', 'volume': '9', 'author': 'Purdie', 'year': '1994', 'journal-title': 'Oncogene'}
/ Oncogene / Tumor-incidence, spectrum and ploidy in mice with a large deletion in the p53 gene by Purdie (1994)10.1002/(SICI)1096-9896(199901)187:1<43::AID-PATH246>3.0.CO;2-P
/ J. Pathol. / Insights into cancer from transgenic mouse models by MacLeod (1999)10.1093/emboj/17.16.4657
/ EMBO J. / Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation by Venkatachalam (1998){'key': '10.1016/S1383-5742(01)00075-8_BIB130', 'first-page': '263', 'article-title': 'p53 wild-type and p53 nullizygous Big Blue© transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain', 'volume': '11', 'author': 'Nishino', 'year': '1995', 'journal-title': 'Oncogene'}
/ Oncogene / p53 wild-type and p53 nullizygous Big Blue© transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain by Nishino (1995)10.1016/S0027-5107(97)00078-X
/ Mutat. Res. / Spontaneous mutation frequencies and spectra in p53+/+ and p53−/− mice: a test of the guardian of the genome hypothesis in the Big Blue© transgenic mouse mutation detection systems by Buettner (1997){'key': '10.1016/S1383-5742(01)00075-8_BIB132', 'first-page': '2407', 'article-title': 'Increased mutation frequency and altered spectrum in one of four lymphomas derived from tumor prone p53/Big Blue© double transgenic mice', 'volume': '13', 'author': 'Buettner', 'year': '1996', 'journal-title': 'Oncogene'}
/ Oncogene / Increased mutation frequency and altered spectrum in one of four lymphomas derived from tumor prone p53/Big Blue© double transgenic mice by Buettner (1996)10.1073/pnas.92.18.8517
/ Proc. Natl. Acad. Sci. / p53 deficiency does not affect the accumulation of point mutations in a transgene target by Sands (1995){'key': '10.1016/S1383-5742(01)00075-8_BIB134', 'first-page': '1188', 'article-title': 'High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination', 'volume': '57', 'author': 'Gupta', 'year': '1997', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination by Gupta (1997)10.1073/pnas.96.16.9230
/ Proc. Natl. Acad. Sci. / Mitotic recombination produces the majority of recessive fiborblast variants in heterozygous mice by Shao (1999)10.1073/pnas.97.13.7405
/ Proc. Natl. Acad. Sci. / Chromosome instability contributes to loss of heterozygosity in mice lacking p53 by Shao (2000){'key': '10.1016/S1383-5742(01)00075-8_BIB137', 'first-page': '1572', 'article-title': 'Direct molecular identification of the mouse pink-eyed unstable mutation by genome scanning', 'volume': '266', 'author': 'Brilliant', 'year': '1991', 'journal-title': 'Science'}
/ Science / Direct molecular identification of the mouse pink-eyed unstable mutation by genome scanning by Brilliant (1991)10.1073/pnas.90.1.297
/ Proc. Natl. Acad. Sci. / High frequency genetic reversion mediated by a DNA duplication: the mouse pink-eyed unstable mutation by Gondo (1993)10.1126/science.7985029
/ Science / Reversion of the mouse pink-eyed unstable mutation induced by low doses of X-rays by Schiestl (1994)10.1093/carcin/20.12.2229
/ Carcinogenesis / Involvement of p53 in X-ray induced intrachromosomal recombination in mice by Aubrecht (1999)10.1038/377169a0
/ Nature / Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene Xpa by De Vries (1995)10.1002/(SICI)1098-2280(1999)34:2/3<124::AID-EM11>3.0.CO;2-F
/ Environ. Mol. Mutagen. / Effect of heterozygous loss of p53 on benzo(a)pyrene induced mutations and tumors in DNA-repair-deficient Xpa mice by van Oostrom (1999)10.1016/S0378-4274(01)00297-1
/ Toxicol. Lett. / The role of excision repair and loss of p53 in mutagenesis and carcinogenesis by van Steeg (2001)10.1038/sj.onc.1200871
/ Oncogene / Absence of p53 permits propagation of mutant cells following genotoxic damage by Griffiths (1997)10.1038/sj.onc.1201867
/ Oncogene / Mutant p53 protein expression interferes with p53-independent apoptotic pathways by Li (1998){'key': '10.1016/S1383-5742(01)00075-8_BIB146', 'first-page': '1489', 'article-title': 'Suppression of apoptosis by bcl-2 and bcl-xl promotes susceptibility to mutagenesis', 'volume': '19', 'author': 'Cherbonnel-Lassere', 'year': '1996', 'journal-title': 'Oncogene'}
/ Oncogene / Suppression of apoptosis by bcl-2 and bcl-xl promotes susceptibility to mutagenesis by Cherbonnel-Lassere (1996)10.1016/S0300-9084(97)82011-1
/ Biochimie / Suppression of apoptosis by overexpression of bcl-2 or bcl-xl promotes survival and mutagenesis after oxidative damage by Cherbonnel-Lassere (1997)10.1016/S0027-5107(98)00234-6
/ Mutat. Res. / TK+/− mouse model for detecting in vivo mutation in an endogenous, autosomal gene by Doborovolsky (1999)10.1073/pnas.97.8.4174
/ Proc. Natl. Acad. Sci. / High metastatic potential in mice inheriting a targeted p53 missense mutation by Liu (2000)
Dates
Type | When |
---|---|
Created | 22 years, 10 months ago (Oct. 14, 2002, 6:58 p.m.) |
Deposited | 4 years, 8 months ago (Dec. 3, 2020, 2:30 a.m.) |
Indexed | 4 weeks, 2 days ago (July 28, 2025, 6 p.m.) |
Issued | 23 years, 5 months ago (March 1, 2002) |
Published | 23 years, 5 months ago (March 1, 2002) |
Published Print | 23 years, 5 months ago (March 1, 2002) |
@article{Morris_2002, title={A role for p53 in the frequency and mechanism of mutation}, volume={511}, ISSN={1383-5742}, url={http://dx.doi.org/10.1016/s1383-5742(01)00075-8}, DOI={10.1016/s1383-5742(01)00075-8}, number={1}, journal={Mutation Research/Reviews in Mutation Research}, publisher={Elsevier BV}, author={Morris, Suzanne M}, year={2002}, month=mar, pages={45–62} }